Michael S. Mulligan, M.D.
Patient Services:UWMC Thoracic Surgery Clinic, Tuesdays, 1-5 pm See also: Academic Office:Phone: 206-543-3093 E-mail: Fax: 206-543-0325 Address: |
Associate Professor
Faculty Appointments:
University of Washington, Associate Professor, 2003- present.
University of Washington, Assistant Professor, 1999 - 2003.
University of Michigan, Lecturer in Thoracic Surgery, 1998-99.
Education:
Fellowships: University of Michigan, Department
of Pathology, Research, 1989-92.
University of Michigan, Heart and Lung Transplantation, 1995-96.
University of Michigan, Thoracic Surgery, 1996-98.
University of Michigan, General Thoracic Surgery, 1998-99.
Residency: Columbia-Presbyterian Medical
Center, 1992-95.
M.D. Degree: University of Connecticut, 1989.
Clinical Interests:
Lung transplantation, thromboembolic pulmonary hypertension, lung volume reduction surgery, benign and malignant lung & esophageal disease.
See also:
Dr. Mulligan's streaming radio webcast: "Lung cancer: Expert research and new treatments"
Research Interests:
Regulation of broncholitis obliterans, mediators involved in acute transplant dysfunction, cytokine and adhesion molecule regulation of acute lung injury.
download Annual Research Report 
Selected Publications:
Mulligan MS, Lentsch AB, Huber-Lang M, Ren-Feng G, Sarma V, Wright CD, Ulich TR, Ward PA. Anit-Inflammatory Effects of Mutant Forms of Secretory Leukocyte Protease Inhibitor. Am J Pathol, 164(5):2650-9. 2000.
Mulligan MS, Warner RL, Ritterhaus C, Thomas LJ, Ryan US, Foreman KE, Crouce LD, Till GO, Ward PA. Endothelial Targeting and Enhanced Anti-inflammatory Effects of Complement Inhibitors Possessing Sialyl Lewis X Moieties. J Immunol, 162(8):4952-9. 1999.
reviewed 01/03